Zepp Health Corporation

NYSE: ZEPP · Real-Time Price · USD
33.53
-1.58 (-4.50%)
At close: Aug 15, 2025, 12:37 PM

Zepp Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
59.41M 38.54M 59.54M 42.46M 295.33M 287.23M 599.7M 602.1M 648.34M 645.18M 1.07B 1.21B 1.11B 757.05M 1.66B 1.61B 1.84B 1.15B
Cost of Revenue
37.91M 24.18M 37.61M 25.22M 176.44M 181.56M 391.38M 398.02M 505.8M 542.34M 849.88M 975.11M 909.95M 604.81M 1.34B 1.28B 1.43B 889.06M
Gross Profit
21.49M 14.36M 21.93M 17.24M 118.89M 105.67M 208.32M 204.08M 142.54M 102.84M 221.85M 230.69M 198.34M 152.24M 320.65M 323.75M 403.04M 258.2M
Operating Income
-6.1M -18.38M -8.94M -12.54M -9.87M -113.74M 5.34M 10.84M -72.37M -150.91M -70.95M -73.26M -110.6M -155.43M 10.07M 62.48M 71.6M -50.2M
Interest Income
295K 581K 771K 941K 948K 1.01M 5.96M 812K 848K 600.56K 670.26K 458.6K 320.51K 400.62K 481.37K 552.1K 699.91K 870.25K
Pretax Income
-6.99M -19.27M -20.48M -12.79M -10.46M -101.22M -5.96M 3.62M -75.73M -158.72M -77.54M -54.23M -131.65M -109.11M 21.91M 54.3M 79.07M -48.62M
Net Income
-7.74M -19.74M -36.88M -13.25M -10.84M -105.52M -8.43M 2.98M -69.94M -133.98M -75.03M -20.63M -118.63M -92.37M 36.31M 49.34M 92.57M -40.43M
Selling & General & Admin
16.43M 20.36M 19.81M 18.92M 15.41M 123.27M 122.98M 118.59M 125.62M 135.88M 178.46M 176.56M 179.95M 161.27M 216.8M 152.61M 171.13M 156.07M
Research & Development
11.16M 12.38M 11.06M 10.86M 78.61M 96.14M 80M 74.64M 89.29M 117.87M 114.34M 127.38M 128.99M 146.41M 93.78M 108.66M 160.3M 152.33M
Other Expenses
n/a n/a n/a n/a n/a 489K 839K -1.73M -783K -1.99M -514K n/a 2.32M n/a n/a 1.74M -216K 2.5M
Operating Expenses
27.59M 32.74M 30.87M 29.78M 190.58M 219.41M 202.98M 193.24M 214.91M 253.75M 292.8M 303.95M 308.94M 307.67M 310.59M 261.27M 331.44M 308.4M
Interest Expense
1.25M 1.36M 1.45M 1.29M 1.37M 1.44M 10.39M 1.61M 1.76M 1.94M 2.52M 2.12M 2.11M 1.84M 2.33M 2.08M 1.6M 1.01M
Selling & Marketing Expenses
12.05M 13.84M 13.25M 11.9M 10.55M 77.31M 86.47M 70.56M 71.55M 85.98M 125.09M 123.85M 108.25M 103.11M 152.1M 90.7M 104.69M 90.79M
Cost & Expenses
65.51M 56.91M 68.48M 55M 367.02M 400.97M 594.36M 591.26M 720.72M 796.09M 1.14B 1.28B 1.22B 912.48M 1.65B 1.54B 1.76B 1.2B
Income Tax Expense
242K 110K 13.57M 465K 47K 514K 20.05M 475K -11.61M -24.73M -2.5M -33.61M -13.02M -16.75M 507K 6.23M 11.61M -7.6M
Shares Outstanding (Basic)
3.96M 3.86M 4.04M 16.15M 16.18M 16.22M 15.1M 16.01M 15.07M 15.26M 15.23M 15.26M 15.19M 15.59M 15.85M 15.78M 15.74M 15.67M
Shares Outstanding (Diluted)
3.96M 4.01M 4.04M 16.15M 16.18M 16.22M 15.1M 16.01M 15.22M 15.32M 15.3M 15.32M 15.36M 15.59M 16.52M 16.64M 16.47M 15.67M
EPS (Basic)
-1.92 -5.12 -9.12 -0.82 -0.68 -6.52 -0.56 0.19 -4.64 -8.8 -4.92 -1.36 -7.8 -5.92 2.24 3.20 5.92 -2.56
EPS (Diluted)
-1.92 -5.12 -9.12 -0.82 -0.68 -6.52 -0.56 0.19 -4.6 -8.76 -4.92 -1.36 -7.72 -5.92 2.24 3.04 5.60 -2.56
EBITDA
-5.75M -17.91M -19.03M -11.51M -9.09M -105.97M 12.13M 25.5M -67.21M -148.76M -67.09M -31.72M -106.13M -149.14M 23.04M 69.26M 78.38M -41.97M
EBIT
-5.75M -17.91M -19.03M -11.51M -9.09M -12.77M -151.25K 2.1M -9.11M -21.13M -10.08M -5.49M -17.54M -15.33M 5.97M 10.47M 13.83M -6.38M
Depreciation & Amortization
n/a n/a n/a 1.03M 7.81M 13.61M 13.61M 14.65M 14.65M 14.65M 14.65M 12.97M 12.97M 12.97M 12.97M 6.78M 6.78M 6.78M